Salvia BioElectronics secures $60M in oversubscribed Series B to bring its pioneering migraine therapy to market

Series B funding round led by Innovation Industries, with participation from Invest-NL, EIC Fund, and existing investors Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant Development Agency (BOM) and Thuja Capital. Read more [Source: salviabioelectronics.com]

Share This Story, Choose Your Platform!

Facebook
Twitter
LinkedIn

Bedrijven

Producten & werkwijze

Membership

Jobs